Skip to main content
Equibles

Stone House Investment Management, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 1696497 TUNKHANNOCK, PA
Back to VKTX Full portfolio

Position in VKTX

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$31,208
+$5,176 QoQ
Shares Held
800
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#346
of 436 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in VKTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Stone House Investment Management, LLC holds $550,462 across 71 Biotechnology names. VKTX ranks #7 (5.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 AUPH
Aurinia Pharmaceuticals Inc.
 6,693 $113,580
2 ORKA
Oruka Therapeutics, Inc.
 902 $85,843
3 TGTX
Tg Therapeutics, Inc.
 1,008 $55,379
4 INSM
INSMED Inc
 501 $53,416
5 DFTX
Definium Therapeutics, Inc.
 1,000 $47,040
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 78 $38,744
7 VKTX
Viking Therapeutics, Inc.
This page 		800 $31,208
8 STOK
Stoke Therapeutics, Inc.
 500 $16,360

All Filings in VKTX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,208 800
2026-03-31 $26,032 800
2025-12-31 $28,144 800
2025-09-30 $21,024 800
2025-06-30 $21,200 800
2025-03-31 $7,245 300
2024-09-30 $31,655 500
2024-06-30 $15,903 300
2024-03-31 $24,600 300
2023-12-31 $4,652 250
2023-09-30 $2,767 250
2023-06-30 $4,052 250